Skip to main content

USPSTF: Evidence Still Lacking for Iron Deficiency Screening in Pregnancy

Medically reviewed by Carmen Pope, BPharm. Last updated on Aug 20, 2024.

By Elana Gotkine HealthDay Reporter

TUESDAY, Aug. 20, 2024 -- The U.S. Preventive Services Task Force (USPSTF) concludes that the current evidence is insufficient to weigh the balance of benefits and harms for recommending screening for iron deficiency and iron deficiency anemia in pregnancy. These findings form the basis of a final recommendation statement published online Aug. 20 in the Journal of the American Medical Association.

Amy G. Cantor, M.D., M.P.H., from the Oregon Health & Science University in Portland, and colleagues conducted a systematic review to update the 2015 USPSTF recommendations on screening for iron deficiency anemia and iron deficiency during pregnancy. Data were included from 17 trials (24,023 participants). The researchers found that based on four and six trials, iron supplementation was associated with a reduced risk for maternal iron deficiency anemia at term (relative risk, 0.40) and maternal iron deficiency at term (relative risk, 0.47) compared with placebo or no iron supplement. Compared with placebo or no supplementation, maternal iron supplements were not associated with maternal or infant adverse effects. Transient gastrointestinal adverse effects were harms of iron supplementation.

Based on these findings, the USPSTF concludes that the current evidence is insufficient for assessing the balance of benefits and harms of screening for iron deficiency and iron deficiency anemia in asymptomatic pregnant women (I statement). In addition, the current evidence is insufficient for ascertaining the balance of benefits and harms of iron supplementation in asymptomatic pregnant women on maternal and infant health outcomes (I statement).

"We don't have the evidence we need to determine whether or not screening for iron levels or using iron supplements improve health, so we are calling for more research on both these important topics," USPSTF member Esa Davis, M.D., M.P.H., said in a statement

Evidence Report

Final Recommendation Statement

Editorial 1

Editorial 2

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted August 2024

Read this next

Smoking Before or During Pregnancy Tied to Severe Neonatal Morbidity

FRIDAY, Aug. 23, 2024 -- Maternal cigarette smoking before or during pregnancy increases the risk for severe neonatal morbidity (SNM), according to a study published online Aug...

Study Reveals Pregnancy Challenges for Those With Intellectual Disabilities

THURSDAY, Aug. 22, 2024 -- Pregnant people with intellectual and developmental disabilities (IDD) tend to be younger at first delivery, have fewer live births, and have higher...

Study Looks at Impact of Hypothyroidism, Hypothyroxinemia in Pregnancy

WEDNESDAY, Aug. 21, 2024 -- For women with subclinical hypothyroidism (SH) or hypothyroxinemia (HT) diagnosed during the first half of pregnancy, SH is associated with higher...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.